$101.24
1.15% today
NYSE, Sep 22, 07:45 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$100.09
-4.22 4.05% 1M
-12.82 11.35% 6M
-5.54 5.24% YTD
-6.25 5.88% 1Y
-13.31 11.74% 3Y
-29.91 23.01% 5Y
+4.83 5.07% 10Y
+31.56 46.05% 20Y
NYSE, Closing price Fri, Sep 19 2025
-0.12 0.12%

Key metrics

Basic
Market capitalization
$20.0b
Enterprise Value
$27.0b
Net debt
$7.0b
Cash
$556.9m
Shares outstanding
197.9m
Valuation (TTM | estimate)
P/E
24.1 | 12.2
P/S
2.6 | 2.4
EV/Sales
3.5 | 3.3
EV/FCF
22.7
P/B
1.6
Dividends
DPS
$0.96
Yield 1Y | 5Y
1.0% | 0.8%
Growth 1Y | 5Y
0.0% | 0.6%
Payout 1Y | 3Y
21.7% | 27.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$7.8b | $8.3b
EBITDA
$2.1b | $2.9b
EBIT
$1.5b | $2.3b
Net Income
$823.4m | $1.6b
Free Cash Flow
$1.2b
Growth (TTM | estimate)
Revenue
4.1% | 8.2%
EBITDA
0.8% | 34.4%
EBIT
-1.6% | 45.2%
Net Income
-17.4% | 80.3%
Free Cash Flow
43.8%
Margin (TTM | estimate)
Gross
71.1%
EBITDA
27.1% | 34.8%
EBIT
19.3%
Net
10.5% | 19.6%
Free Cash Flow
15.2%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.3%
ROCE
7.5%
ROIC
6.3%
Debt/Equity
0.6
More
EPS
$4.2
FCF per Share
$6.0
Short interest
3.4%
Employees
17k
Rev per Employee
$450.0k
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

14x Buy
41%
18x Hold
53%
2x Sell
6%

Analyst Opinions

34 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
41%
Hold
53%
Sell
6%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7,834 7,834
4% 4%
100%
- Direct Costs 2,267 2,267
7% 7%
29%
5,567 5,567
3% 3%
71%
- Selling and Administrative Expenses 2,997 2,997
5% 5%
38%
- Research and Development Expense 444 444
1% 1%
6%
2,126 2,126
1% 1%
27%
- Depreciation and Amortization 617 617
7% 7%
8%
EBIT (Operating Income) EBIT 1,508 1,508
2% 2%
19%
Net Profit 823 823
17% 17%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Neutral
Seeking Alpha
14 days ago
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT Company Participants Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Re...
Neutral
PRNewsWire
18 days ago
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer Biomet's wholly owned subsidiary, Paragon 28, will feature a suite of industry-leading foot and ankle products.
Neutral
PRNewsWire
25 days ago
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M.
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 17,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today